BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18065303)

  • 1. The evolving means of protecting horses against West Nile infection through immunisation.
    Traub-Dargatz JL; Cordes T; Evans MB
    Equine Vet J; 2007 Nov; 39(6):484-5. PubMed ID: 18065303
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.
    Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003.
    Epp T; Waldner C; Townsend HG
    Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses.
    Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP
    Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study: West Nile virus cost equine industries in Colorado, Nebraska millions in 2002.
    J Am Vet Med Assoc; 2003 Jun; 222(12):1669, 1672. PubMed ID: 12830851
    [No Abstract]   [Full Text] [Related]  

  • 6. Surveillance for antibodies to West Nile virus in Ireland.
    Raleigh PJ; Sammin DJ; Connell J; Markey BK; O'Connor M
    Vet Rec; 2012 Feb; 170(7):180. PubMed ID: 22238203
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. West Nile Virus: is a vaccine needed?
    Martina BE; Koraka P; Osterhaus AD
    Curr Opin Investig Drugs; 2010 Feb; 11(2):139-46. PubMed ID: 20112163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ChimeriVax-West Nile vaccine.
    Hall RA; Khromykh AA
    Curr Opin Mol Ther; 2007 Oct; 9(5):498-504. PubMed ID: 17932814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.
    El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses.
    Ward MP; Schuermann JA; Highfield LD; Murray KO
    Vet Microbiol; 2006 Dec; 118(3-4):255-9. PubMed ID: 16971067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus.
    Beasley DW
    Immunotherapy; 2011 Feb; 3(2):269-85. PubMed ID: 21322763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avian titer development against West nile virus after extralabel use of an equine vaccine.
    Johnson S
    J Zoo Wildl Med; 2005 Jun; 36(2):257-64. PubMed ID: 17323567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can West Nile virus outbreaks be controlled?
    Lustig S; Halevy M; Fuchs P; Ben-Nathan D; Lachmi BE; Kobiler D; Israeli E; Olshevsky U
    Isr Med Assoc J; 2000 Oct; 2(10):733-7. PubMed ID: 11344722
    [No Abstract]   [Full Text] [Related]  

  • 15. West Nile virus: recent trends in diagnosis and vaccine development.
    Dauphin G; Zientara S
    Vaccine; 2007 Jul; 25(30):5563-76. PubMed ID: 17292514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping and analysis of West Nile virus-specific monoclonal antibodies: prospects for vaccine development.
    Throsby M; Ter Meulen J; Geuijen C; Goudsmit J; de Kruif J
    Expert Rev Vaccines; 2007 Apr; 6(2):183-91. PubMed ID: 17408368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technologies for the development of West Nile virus vaccines.
    Ulbert S; Magnusson SE
    Future Microbiol; 2014; 9(10):1221-32. PubMed ID: 25405890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. West Nile virus and other exotic diseases of horses.
    Aust Vet J; 2003 Aug; 81(8):456-7. PubMed ID: 15086077
    [No Abstract]   [Full Text] [Related]  

  • 19. [Introduction of West Nile virus in the Netherlands].
    Klinkhamer K; Lipman LJ
    Tijdschr Diergeneeskd; 2008 Feb; 133(3):106-7. PubMed ID: 18309824
    [No Abstract]   [Full Text] [Related]  

  • 20. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
    Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.